If you purchased or paid for brand-name or generic Lidoderm, you may be entitled to compensation from a $105 million class action settlement. Find out if you qualify now!
This website has been established to provide general information related to the proposed settlement of the case referred to as In re Lidoderm Antitrust Litigation.
If you purchased brand Lidoderm directly from Endo Pharmaceuticals Inc. or generic lidocaine 5% patch (generic Lidoderm) directly from Actavis, Inc. (f/k/a Watson Pharmaceuticals, Inc.) between August 23, 2012 through May 1, 2014. You could
SAN FRANCISCO (CN) – A federal judge on Thursday finalized two class action settlements worth $270 million, ending four years of litigation over an alleged antitrust conspiracy to keep a generic form of the Lidoderm pain patch off the market
Girard Sharp is a national law firm committed to protecting the rights of individuals, businesses, and institutional clients in courts and arbitral tribunals across the United States. We offer innovative solutions to clients who have been harmed
A California federal judge on Wednesday approved “excellent” settlements ending claims that Teikoku, Endo and Actavis violated antitrust laws by stalling the release of a generic form of the Lidode